Deborah Dunsire - Sep 9, 2021 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Director
Signature
/s/ Gerald E. Quirk, as attorney-in-fact
Stock symbol
SYRS
Transactions as of
Sep 9, 2021
Transactions value $
$0
Form type
3
Date filed
9/10/2021, 05:27 PM
Previous filing
Jul 23, 2021
Next filing
Jun 2, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney